The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Pharmacological Actions of Cannabinoids
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ahluwalia, J., Yaqoob, M., Urbán, L., Bevan, S., & Nagy, I. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01550.x · Cited by 85
RetractedInternational Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Self-citationStructure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,614
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Self-citationInternational Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Self-citationVanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1
Jordt, S.-E., Bautista, D. M., Chuang, H.-H., McKemy, D. D., Zygmunt, P. M., Högestätt, E. D., Meng, I. D., & Julius, D. (2004) · Nature · doi:10.1038/nature02282 · Cited by 1,899
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Pharmacology of cannabinoid CB1 and CB2 receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,470
Self-citationBisogno, T., Hanuš, L., De Petrocellis, L., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Di Marzo, V. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,311
Monastyrsky, M. (1999) · Riemann, Topology, and Physics · doi:10.1007/978-0-8176-4779-7_2 · Cited by 1,078
Control of pain initiation by endogenous cannabinoids
Calignano, A., Rana, G. L., Giuffrida, A., & Piomelli, D. (1998) · Nature · doi:10.1038/28393 · Cited by 1,056
Felder, C. C., Joyce, K. E., Briley, E. M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A. L., & Mitchell, R. L. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10492-6 · Cited by 869
Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants
Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor
Hanuš, L., Abu-Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D. E., Kustanovich, I., & Mechoulam, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061029898 · Cited by 762
Cannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741
Self-citationIversen, L. (2003) · Brain · doi:10.1093/brain/awg143 · Cited by 732
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
Di Marzo, V., Melck, D., Bisogno, T., & De Petrocellis, L. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01283-1 · Cited by 712
SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
Rinaldi-Carmona, M., Barth, F., Millan, J., Derocq, J.-M., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37266-0 · Cited by 709
Molecular cloning of a human cannabinoid receptor which is also expressed in testis
Gérard, C. M., Mollereau, C., Vassart, G., & Parmentier, M. (1991) · Biochemical Journal · doi:10.1042/bj2790129 · Cited by 687
Modulation of transmitter release via presynaptic cannabinoid receptors
Schlicker, E., & Kathmann, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01805-8 · Cited by 671
Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration
Walter, L., Franklin, A., Witting, A., Wade, C., Xie, Y., Kunos, G., Mackie, K., & Stella, N. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01398.2003 · Cited by 665
Glass, M., & Felder, C. C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05327.1997 · Cited by 635
Ben-Shabat, S., Fride, E., Sheskin, T., Tamiri, T., Rhee, M.-H., Vogel, Z., Bisogno, T., De Petrocellis, L., Di Marzo, V., & Mechoulam, R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00392-6 · Cited by 629
Porter, A. C., Sauer, J.-M., Knierman, M. D., Becker, G. W., Berna, M. J., Bao, J., Nomikos, G. G., Carter, P., Bymaster, F. P., Leese, A. B., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1020 · Cited by 615
Anandamide and vanilloid TRPV1 receptors
Ross, R. A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705467 · Cited by 604
Járai, Z., Wagner, J. A., Varga, K., Lake, K. D., Compton, D. R., Martin, B. R., Zimmer, A. M., Bonner, T. I., Buckley, N. E., Mezey, E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14136 · Cited by 599
Showalter, V. M., Compton, D. R., Martin, B. R., & Abood, M. E. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20744-3 · Cited by 571
HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor
Hanuš, L., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., & Fride, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14228 · Cited by 571
Self-citationCannabinoid receptors and their ligands
Pertwee, R. G., & Ross, R. A. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0341 · Cited by 561
Self-citationEvidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain
Breivogel, C. S., Griffin, G., Di Marzo, V., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 541
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations
Hájos, N., Katona, I., Naiem, S. S., Mackie, K., Ledent, C., Mody, I., & Freund, T. F. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00217.x · Cited by 533
Pharmacology of Cannabinoid Receptor Ligands
Pertwee, R. G. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401124036 · Cited by 526
Self-citationCannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors
Richardson, J. D., Kilo, S., & Hargreaves, K. M. (1998) · Pain · doi:10.1016/s0304-3959(97)00213-3 · Cited by 500
Ibrahim, M. M., Deng, H., Zvonok, A., Cockayne, D. A., Kwan, J., Mata, H. P., Vanderah, T. W., Lai, J., Porreca, F., Makriyannis, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834309100 · Cited by 491
Felder, C. C., Briley, E. M., Axelrod, J., Simpson, J. T., Mackie, K., & Devane, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7656 · Cited by 475
Sim, L. J., Selley, D. E., & Childers, S. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7242 · Cited by 455
Structure−Activity Relationships of Pyrazole Derivatives as Cannabinoid Receptor Antagonists
Lan, R., Liu, Q., Fan, P., Lin, S., Fernando, S. R., McCallion, D., Pertwee, R., & Makriyannis, A. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980363y · Cited by 447
Self-citationInverse agonism and neutral antagonism at cannabinoid CB1 receptors
Pertwee, R. G. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.10.025 · Cited by 444
Self-citationMechoulam, R., Fride, E., & Di Marzo, V. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00649-9 · Cited by 428
Hájos, N., Ledent, C., & Freund, T. F. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00287-1 · Cited by 419
Ross, R. A., Brockie, H. C., Stevenson, L. A., Murphy, V. L., Templeton, F., Makriyannis, A., & Pertwee, R. G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702351 · Cited by 404
Self-citationDi Marzo, V., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., Zimmer, A., & Martin, B. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752434.x · Cited by 393
BISOGNO, T., MELCK, D., BOBROV, M. Y., GRETSKAYA, N. M., BEZUGLOV, V. V., De PETROCELLIS, L., & Di MARZO, V. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510817 · Cited by 381
Howlett, A. C., & Fleming, R. M. (1984) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15066-9 · Cited by 375
Hillard, C. J., Manna, S., Greenberg, M. J., DiCamelli, R., Ross, R. A., Stevenson, L. A., Murphy, V., Pertwee, R. G., & Campbell, W. B. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38289-8 · Cited by 374
Self-citationSugiura, T., Kondo, S., Kishimoto, S., Miyashita, T., Nakane, S., Kodaka, T., Suhara, Y., Takayama, H., & Waku, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.605 · Cited by 371
Gonsiorek, W., Lunn, C., Fan, X., Narula, S., Lundell, D., & Hipkin, R. W. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26516-0 · Cited by 369
Mackie, K., Devane, W. A., & Hille, B. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13215-x · Cited by 362
Compton, D. R., Aceto, M. D., Lowe, J., & Martin, B. R. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12911-x · Cited by 357
De Petrocellis, L., Bisogno, T., Maccarrone, M., Davis, J. B., Finazzi-Agrò, A., & Di Marzo, V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008555200 · Cited by 355
(R)-Methanandamide: A Chiral Novel Anandamide Possessing Higher Potency and Metabolic Stability
Abadji, V., Lin, S., Taha, G., Griffin, G., Stevenson, L. A., Pertwee, R. G., & Makriyannis, A. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00038a020 · Cited by 346
Self-citationAn Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing
Shire, D., Carillon, C., Kaghad, M., Calandra, B., Rinaldi-Carmona, M., Fur, G. L., Caput, D., & Ferrara, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.3726 · Cited by 330
A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation
Dinh, T. P., Freund, T. F., & Piomelli, D. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00150-0 · Cited by 320
Marsicano, G., Moosmann, B., Hermann, H., Lutz, B., & Behl, C. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00716.x · Cited by 315
Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide
Chemin, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7033 · Cited by 299
Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential
(2003) · Choice Reviews Online · doi:10.5860/choice.40-3432 · Cited by 293
Huffman, J. W., Liddle, J., Yu, S., Aung, M. M., Abood, M. E., Wiley, J. L., & Martin, B. R. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00219-9 · Cited by 288
Mechanism of Cannabinoid Effects on Long-Term Potentiation and Depression in Hippocampal CA1 Neurons
Misner, D. L., & Sullivan, J. M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-16-06795.1999 · Cited by 285
Structural Requirements for Binding of Anandamide-Type Compounds to the Brain Cannabinoid Receptor
Sheskin, T., Hanuš, L., Slager, J., Vogel, Z., & Mechoulam, R. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960752x · Cited by 275
Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide
Facchinetti, F., Del Giudice, E., Furegato, S., Passarotto, M., & Leon, A. (2003) · Glia · doi:10.1002/glia.10177 · Cited by 275
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines
Massi, P., Vaccani, A., Ceruti, S., Colombo, A., Abbracchio, M. P., & Parolaro, D. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061002 · Cited by 271
Marinelli, S., Di Marzo, V., Berretta, N., Matias, I., Maccarrone, M., Bernardi, G., & Mercuri, N. B. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03136.2003 · Cited by 258
Mesenteric Vasodilation Mediated by Endothelial Anandamide Receptors
Wagner, J. A., Varga, K., Járai, Z., & Kunos, G. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.429 · Cited by 257
Hillard, C. J. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00051-4 · Cited by 254
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide
Calignano, A., La Rana, G., & Piomelli, D. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00988-8 · Cited by 241
Ross, R. A., Gibson, T. M., Brockie, H. C., Leslie, M., Pashmi, G., Craib, S. J., Di Marzo, V., & Pertwee, R. G. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703850 · Cited by 237 · cited 2×
“It is noteworthy, however, that anandamide has less TRPV1 intrinsic activity than the well-known TRPV1 receptor agonist capsaicin (Ross 2003; Ross et al. 2001).”
BackgroundEl-Remessy, A. B., Khalil, I. E., Matragoon, S., Abou-Mohamed, G., Tsai, N.-J., Roon, P., Caldwell, R. B., Caldwell, R. W., Green, K., & Liou, G. I. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63558-4 · Cited by 235
Felder, C. C., Joyce, K. E., Briley, E. M., Glass, M., Mackie, K. P., Fahey, K. J., Cullinan, G. J., Hunden, D. C., Johnson, D. W., Chaney, M. O., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37189-7 · Cited by 233
Franklin, A., Parmentier-Batteur, S., Walter, L., Greenberg, D. A., & Stella, N. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07767.2003 · Cited by 231
Cannabinoids and brain injury: therapeutic implications
Mechoulam, R. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02276-1 · Cited by 229
Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor
Offertáler, L., Mo, F.-M., Bátkai, S., Liu, J., Begg, M., Razdan, R. K., Martin, B. R., Bukoski, R. D., & Kunos, G. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.699 · Cited by 228
Barann, M., Molderings, G., Brüss, M., Bönisch, H., Urban, B. W., & Göthert, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704829 · Cited by 215
Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor
Shire, D., Calandra, B., Rinaldi-Carmona, M., Oustric, D., Pessègue, B., Bonnin-Cabanne, O., Le Fur, G., Caput, D., & Ferrara, P. (1996) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(96)00047-4 · Cited by 208
Pertwee, R. G. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.7.1553 · Cited by 208
Self-citationCloning and Pharmacological Characterization of the Rat CB2 Cannabinoid Receptor
Griffin, G., Tao, Q., & Abood, M. E. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35367-4 · Cited by 207
Song, Z. H., & Bonner, T. I. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09082-0 · Cited by 206
Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors
De Petrocellis, L., Davis, J. B., & Di Marzo, V. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02934-9 · Cited by 204
Neuroprotective Antioxidants from Marijuanaa
HAMPSON, A. J., GRIMALDI, M., LOLIC, M., WINK, D., ROSENTHAL, R., & AXELROD, J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06193.x · Cited by 203
Cellular accumulation of anandamide: consensus and controversy
Hillard, C. J., & Jarrahian, A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705468 · Cited by 203
Hájos, N., & Freund, T. F. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00157-0 · Cited by 202
Regional Differences in Cannabinoid Receptor/G-protein Coupling in Rat Brain
Breivogel, C. S., Sim, L. J., & Childers, S. R. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36967-8 · Cited by 202
Iwamura, H., Suzuki, H., Ueda, Y., Kaya, T., & Inaba, T. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38760-9 · Cited by 200
Tognetto, M., Amadesi, S., Harrison, S., Creminon, C., Trevisani, M., Carreras, M., Matera, M., Geppetti, P., & Bianchi, A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01104.2001 · Cited by 195
Cannabinol Derivatives: Binding to Cannabinoid Receptors and Inhibition of Adenylylcyclase
Rhee, M.-H., Vogel, Z., Barg, J., Bayewitch, M., Levy, R., Hanuš, L., Breuer, A., & Mechoulam, R. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970126f · Cited by 191
Conti, S., Costa, B., Colleoni, M., Parolaro, D., & Giagnoni, G. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704466 · Cited by 190
Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons
Fan, P. (1995) · Journal of Neurophysiology · doi:10.1152/jn.1995.73.2.907 · Cited by 186
Breivogel, C. S., Selley, D. E., & Childers, S. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16865 · Cited by 185
Pan, X., Ikeda, S. R., & Lewis, D. L. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1064 · Cited by 185
Petitet, F., Jeantaud, B., Reibaud, M., Imperato, A., & Dubroeucq, M.-C. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00238-0 · Cited by 180
The central neuropharmcology of psychotropic cannabinoids
Pertwee, R. G. (1988) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(88)90106-4 · Cited by 178
Self-citationPertwee, R. G., Ross, R. A., Craib, S. J., & Thomas, A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02624-9 · Cited by 176
Self-citationEvidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors
MacLennan, S. J., Reynen, P. H., Kwan, J., & Bonhaus, D. W. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701915 · Cited by 175
Huffman, J. W., Yu, S., Showalter, V., Abood, M. E., Wiley, J. L., Compton, D. R., Martin, B. R., Bramblett, R. D., & Reggio, P. H. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960394y · Cited by 173
Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals
Griffin, G., Fernando, S. R., Ross, R. A., McKay, N. G., Ashford, M. L. J., Shire, D., Huffman, J. W., Yu, S., Lainton, J. A. H., & Pertwee, R. G. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01336-8 · Cited by 171
Self-citationSugiura, T., Kodaka, T., Kondo, S., Tonegawa, T., Nakane, S., Kishimoto, S., Yamashita, A., & Waku, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1757 · Cited by 164
Hurst, D. P., Lynch, D. L., Barnett-Norris, J., Hyatt, S. M., Seltzman, H. H., Zhong, M., Song, Z.-H., Nie, J., Lewis, D., & Reggio, P. H. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1274 · Cited by 160
Recent Advances in the Chemistry of Hashish
Mechoulam, R., & Gaoni, Y. (1967) · Springer eBooks · doi:10.1007/978-3-7091-8164-5_6 · Cited by 159
Savinainen, J. R., Järvinen, T., Laine, K., & Laitinen, J. T. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704297 · Cited by 159
Head Group Analogs of Arachidonylethanolamide, the Endogenous Cannabinoid Ligand
Khanolkar, A. D., Abadji, V., Lin, S., Hill, W. A. G., Taha, G., Abouzid, K., Meng, Z., Fan, P., & Makriyannis, A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960152y · Cited by 158
Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example
Wager‐Miller, J., Westenbroek, R. E., & Mackie, K. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00151-2 · Cited by 156
Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus In vitro
Marinelli, S., Vaughan, C. W., Christie, M. J., & Connor, M. A. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.022863 · Cited by 155
Smart, D., Jonsson, K., Vandevoorde, S., Lambert, D. M., & Fowler, C. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704732 · Cited by 155
AM630, a competitive cannabinoid receptor antagonist
Pertwee, R. G., Griffin, G., Fernando, S. R., Li, X., Hill, A., & Makriyannis, A. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00175-6 · Cited by 154
Self-citationMunro, S. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)81598-7 · Cited by 154
Dual effect of cannabinoid CB 1 receptor stimulation on a vanilloid VR1 receptor-mediated response
Hermann, H., PETROCELLIS, L. D., Bisogno, T., Moriello, A. S., Lutz, B., & Marzo, V. D. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s000180300052 · Cited by 153
Bayewitch, M. L., Rhee, M. H., Avidor‐Reiss, T., Breuer, A., Mechoulam, R., & Vogel, Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9902 · Cited by 149
Acute Neuronal Injury, Excitotoxicity, and the Endocannabinoid System
van der Stelt, M., Veldhuis, W. B., Maccarrone, M., Bär, P. R., Nicolay, K., Veldink, G. A., Marzo, V. D., & Vliegenthart, J. F. G. (2002) · Molecular Neurobiology · doi:10.1385/mn:26:2-3:317 · Cited by 143
Lin, S., Khanolkar, A. D., Fan, P., Goutopoulos, A., Qin, C., Papahadjis, D., & Makriyannis, A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970257g · Cited by 142
Cannabinoid pharmacological properties common to other centrally acting drugs
Wiley, J. L., & Martin, B. R. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01856-9 · Cited by 140
Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., Brandi, I., Jefferson, R. G., Winckler, R., Davis, J. B., DASSE, O. A., Mahadevan, A., Razdan, R. K., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4354 · Cited by 138
Fride, E., Foox, A., Rosenberg, E., Faigenboim, M., Cohen, V., Barda, L., Blau, H., & Mechoulam, R. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01295-0 · Cited by 138
The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice
Al-Hayani, A., Wease, K. N., Ross, R. A., Pertwee, R. G., & Davies, S. N. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00145-9 · Cited by 137
Self-citationEvaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs.
Adams, I. B., Ryan, W. J., Singer, M. M., Thomas, B. F., Compton, D. M., Razdan, R. K., & Martin, B. R. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09592-8 · Cited by 136
D2 Dopamine Receptors Modulate Gα-Subunit Coupling of the CB1 Cannabinoid Receptor
Jarrahian, A., Watts, V. J., & Barker, E. L. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.057620 · Cited by 135
Farquhar-Smith, P. W., Jaggar, S., & Rice, A. S. C. (2002) · Pain · doi:10.1016/s0304-3959(01)00419-5 · Cited by 133
Jarrahian, A., Manna, S., Edgemond, W. S., Campbell, W. B., & Hillard, C. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742597.x · Cited by 133
Δ9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication
Balster, R. L., & Prescott, W. R. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80051-x · Cited by 133
Rinaldi, M. L., Pialot, F., Congy, C., Redon, E., Barth, F., Bachy, A., Brelière, J.-C., Soubrié, P., & Fur, G. L. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00085-9 · Cited by 132
Endocannabinoids and related fatty acid derivatives in pain modulation
Walker, J. M., Krey, J. F., Chu, C. J., & Huang, S. M. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00152-4 · Cited by 131
Sugiura, T., Kodaka, T., Kondo, S., et al. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021838 · Cited by 129
Zygmunt, P. M., Andersson, D. A., & Högestätt, E. D. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04720.2002 · Cited by 128
Fezza, F., Bisogno, T., Minassi, A., Appendino, G., Mechoulam, R., & Marzo, V. D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02341-4 · Cited by 127
Gatley, S. J., Lan, R., Volkow, N. D., Pappas, N. R., King, P. T., Wong, C., Gifford, A. N., Pyatt, B. E., Dewey, S. L., & Makriyannis, A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010417.x · Cited by 124
Characterization of two cloned human CB1 cannabinoid receptor isoforms.
Rinaldi, M. L., Calandra, B., Shire, D. J., Bouaboula, M., Oustric, D., Barth, F., Casellas, P., Ferrara, P., & Fur, G. L. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20674-7 · Cited by 124
The enzymatic inactivation of the fatty acid amide class of signaling lipids
Cravatt, B. F., & Lichtman, A. H. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00147-0 · Cited by 122
Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition
Hájos, N., & Freund, T. F. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00149-4 · Cited by 121
Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes
Wiley, J. L., & Martin, B. R. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00146-9 · Cited by 120
Maneuf, Y. P., & Brotchie, J. M. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701101 · Cited by 120
Cheer, J. F., Cadogan, A. K., Marsden, C. A., Fone, K. C. F., & Kendal, D. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00208-1 · Cited by 120
Farquhar-Smith, W. P., & Rice, A. S. C. (2001) · Anesthesiology · doi:10.1097/00000542-200103000-00023 · Cited by 116
Lambert, D. M., DiPaolo, F. G., Sonveaux, P., Kanyonyo, M. R., Govaerts, S. J., Hermans, E., Bueb, J., Delzenne, N. M., & Tschirhart, E. J. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00132-8 · Cited by 113
Savinainen, J. R., Saario, S. M., Niemi, R., Järvinen, T., & Laitinen, J. T. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705577 · Cited by 112
Selley, D. E., Stark, S., Sim, L. J., & Childers, S. R. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00347-5 · Cited by 111
Franklin, A., & Stella, N. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02074-0 · Cited by 111
Structure activity relationships of tetrahydrocannabinol analogues on human cannabinoid receptors
Gareau, Y., Dufresne, C., Gallant, M., Rochette, C., Sawyer, N., Slipetz, D. M., Tremblay, N. M., WEECH, P. K., Metters, K. M., & Labelle, M. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00573-c · Cited by 110
Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor
Calandra, B., Portier, M., Kernéis, A., Delpech, M., Carillon, C., Fur, G. L., Ferrara, P., & Shire, D. J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00349-0 · Cited by 108
Breivogel, C. S., & Childers, S. R. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38906-2 · Cited by 106
SR 144528, an Antagonist for the Peripheral Cannabinoid Receptor that Behaves as an Inverse Agonist
Portier, M., Rinaldi, M. L., Pecceu, F., Combes, T., Poinot‐Chazel, C., Calandra, B., Barth, F., Fur, G. L., & Casellas, P. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37993-5 · Cited by 106
Mang, C. F., Erbelding, D., & Kilbinger, H. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704220 · Cited by 104
Tao, Q., & Abood, M. E. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37469-5 · Cited by 102
New class of potent ligands for the human peripheral cannabinoid receptor
Gallant, M., Dufresne, C., Gareau, Y., Guay, D., Leblanc, Y., Prasit, P., Rochette, C., Sawyer, N., Slipetz, D. M., Tremblay, N. M., et al. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00426-x · Cited by 101
PETROCELLIS, L. D., Bisogno, T., Ligresti, A., Bifulco, M., Melck, D. J., & Marzo, V. D. (2002) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2002.00094.x · Cited by 101
The Cannabinoid Agonist WIN55,212-2 Suppresses Opioid-induced Emesis in Ferrets
Simoneau, I. I., Hamza, M., Mata, H. P., Siegel, E. M., Vanderah, T. W., Porreca, F., Makriyannis, A., & Malan, T. P. (2001) · Anesthesiology · doi:10.1097/00000542-200105000-00029 · Cited by 100
Lan, R., Lu, Q., Fan, P., Gatley, J. S., Volkow, N. D., Fernando, S. R., Pertwee, R. G., & Makriyannis, A. (1999) · AAPS PharmSci · doi:10.1208/ps010204 · Cited by 99
Self-citationMauler, F., Mittendorf, J., Horváth, E., & Vry, J. D. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.359 · Cited by 99
The Pharmacology and Therapeutic Potential of Plant Cannabinoids
Cascio, M. G., Pertwee, R. G., & Marini, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-54564-6_9 · Cited by 99
Self-citationHowlett, A. C. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90035-9 · Cited by 98
A Structure/Activity Relationship Study on Arvanil, an Endocannabinoid and Vanilloid Hybrid
Marzo, V. D., Griffin, G., PETROCELLIS, L. D., Brandi, I., Bisogno, T., Williams, W., Grier, M. C., Kulasegram, S., Mahadevan, A., Razdan, R. K., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.984 · Cited by 97
Craib, S. J., Ellington, H. C., Pertwee, R. G., & Ross, R. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704223 · Cited by 95
Self-citationInhibitory effects of SR141716A on G-protein activation in rat brain
Sim‐Selley, L. J., Brunk, L. K., & Selley, D. E. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00784-1 · Cited by 95
Ruiu, S., Pinna, G. A., Marchese, G., Mussinu, J., Saba, P., Tambaro, S., Casti, P., Vargiu, R., & Pani, L. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049924 · Cited by 93
Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents
Fowler, C. J. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00218-7 · Cited by 89
Ferraro, L., Tomasini, M. C., Gessa, G. L., Bebe, B. W., Tanganelli, S., & Antonelli, T. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.8.728 · Cited by 86
Millns, P. J., Chapman, V., & Kendall, D. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703919 · Cited by 85
Helyes, Z., Németh, J., Thán, M., Bölcskei, K., Pintér, E., & Szolcsányi, J. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00651-9 · Cited by 85 · cited 1×
“mouse models of inflammatory or neuropathic pain by acting on a CB2-like receptor (Calignano et al. 1998, 2001; Conti et al. 2002; Farquhar-Smith et al. 2002; Farquhar-Smith and Rice 2001; Helyes et al. 2003).”
BackgroundBrooks, J. W., Pryce, G., Bisogno, T., Jaggar, S., Hankey, D. J. R., Brown, P., Bridges, D., Ledent, C. A., Bifulco, M., Rice, A. S. C., et al. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01369-9 · Cited by 85
Begg, M., Mo, F.-M., Offertáler, L., Bátkai, S., Pacher, P., Razdan, R. K., Lovinger, D. M., & Kunos, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307258200 · Cited by 85
Ueda, N. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00053-9 · Cited by 85
Pertwee, R. G. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00282-9 · Cited by 84
Self-citationYao, L., Fan, P., Jiang, Z., Mailliard, W. S., Gordon, A. S., & Diamond, I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336093100 · Cited by 83
Vasodilator actions of abnormal‐cannabidiol in rat isolated small mesenteric artery
Ho, W. ‐. V., & Hiley, C. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705160 · Cited by 82
Ellington, H. C., Cotter, M. A., Cameron, N. E., & Ross, R. A. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00040-0 · Cited by 82
Fan, S.-F., & Yazulla, S. (2003) · Visual Neuroscience · doi:10.1017/s095252380320208x · Cited by 81
Chin, C., Lucas-Lenard, J. M., Abadji, V., & Kendall, D. A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010366.x · Cited by 76
6ʺ-Azidohex-2ʺ-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist
Thomas, A., Ross, R. A., Saha, B., Mahadevan, A., Razdan, R. K., & Pertwee, R. G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.01.023 · Cited by 76
Self-citationCannabinoid-receptor-independent cell signalling by N-acylethanolamines
Berdyshev, E. V., Schmid, P. C., Krebsbach, R. J., Hillard, C. J., Huang, C., Chen, N., Dong, Z., & Schmid, H. H. O. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600067 · Cited by 75
O‐1057, a potent water‐soluble cannabinoid receptor agonist with antinociceptive properties
Pertwee, R. G., Gibson, T. M., Stevenson, L., Ross, R. A., Banner, W. K., Saha, B., Razdan, R. K., & Martin, B. R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703245 · Cited by 75
Self-citationNeurobehavioral effects of Δ9-THC and cannabinoid (CB1) receptor gene expression in mice
Onaivi, E. S., Chakrabarti, A., Gwebu, E. T., & Chaudhuri, G. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00139-8 · Cited by 75
Novel, Not Adenylyl Cyclase-Coupled Cannabinoid Binding Site in Cerebellum of Mice
Monory, K., Tzavara, E. T., Lexime, J., Ledent, C. A., Parmentier, M., Borsodi, A. D., & Hanoune, J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6635 · Cited by 75
Effect of cannabinoids on neural transmission in rat gastric fundus
Storr, M., Gaffal, E., Saur, D., SCHUSDZIARRA, V., & Allescher, H. D. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-005 · Cited by 74
Kenny, L. C., Baker, P. N., Kendall, D. A., Randall, M. D., & Dunn, W. R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704817 · Cited by 72
Köfalvi, A., Vizi, E. S., Ledent, C. A., & Sperlágh, B. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02897.x · Cited by 71
White, R., & Hiley, C. R. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702127 · Cited by 70
Gallily, R., Even-Chen, T., Katzavian, G., Lehmann, D., Dagan, A., & Mechoulam, R. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000103917 · Cited by 70
Gifford, A. N., Tang, Y., Gatley, S. J., Volkow, N. D., Lan, R., & Makriyannis, A. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00851-3 · Cited by 69
Unsaturated Side Chain β-11-Hydroxyhexahydrocannabinol Analogs
Busch‐Petersen, J., Hill, W. A., Fan, P., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950934b · Cited by 68
Maccarrone, M., Cartoni, A., Parolaro, D., Margonelli, A., Massi, P., Bari, M., Battista, N., & Finazzi‐Agrò, A. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1164 · Cited by 67
In-Vitro and In-Vivo Action of Cannabinoids
Akinshola, B. E., Chakrabarti, A., & Onaivi, E. S. (1999) · Neurochemical Research · doi:10.1023/a:1020968922151 · Cited by 66
Mo, F. M., Offertáler, L., & Kunos, G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.034 · Cited by 66
Öz, M., Zhang, L., & Morales, M. (2002) · Synapse · doi:10.1002/syn.10121 · Cited by 65
Mussinu, J., Ruiu, S., Mulè, A. C., Pau, A., Carai, M. A. M., Loriga, G., Murineddu, G., & Pinna, G. A. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00319-x · Cited by 63
Modulation of peristalsis by cannabinoid CB1 ligands in the isolated guinea‐pig ileum
Izzo, A. A., Mascolo, N., Tonini, M., & Capasso, F. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703116 · Cited by 63
The actions of anandamide on rat superficial medullary dorsal horn neurons in vitro
Jennings, E. A., Vaughan, C. W., Roberts, L. A., & Christie, M. J. (2003) · The Journal of Physiology · doi:10.1111/j.1469-7793.2003.00121.x · Cited by 62
Wrobleski, S. T., Chen, P., Hynes, J. J., Lin, S., Norris, D. J., Pandit, C. R., Spergel, S. H., Wu, H., Tokarski, J. S., Chen, X., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020329q · Cited by 62
Trendelenburg, A., Cox, S. L., Schelb, V., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703305 · Cited by 61
AM630 is an inverse agonist at the human cannabinoid CB1 receptor
Landsman, R. S., Makriyannis, A., Deng, H., Consroe, P. F., Roeske, W. R., & Yamamura, H. I. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)01187-9 · Cited by 61
Paton, G., Pertwee, R. G., & Davies, S. N. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00096-3 · Cited by 61
Self-citationRubovitch, V., Gafni, M., & Sarne, Y. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00174-2 · Cited by 60
Ross, R. A., Gibson, T. M., Stevenson, L., Saha, B., Crocker, P. J., Razdan, R. K., & Pertwee, R. G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702836 · Cited by 58
Self-citationCosenza, M., Gifford, A. N., Gatley, S. J., Pyatt, B. E., Liu, Q., Makriyannis, A., & Volkow, N. D. (2000) · Synapse · doi:10.1002/1098-2396(20001215)38:4<477::aid-syn13>3.0.co;2-y · Cited by 56
Wiley, J. L., Beletskaya, I. D., Ng, E. W., Dai, Z., Crocker, P. J., Mahadevan, A., Razdan, R. K., & Martin, B. R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.679 · Cited by 54
Modulation of cannabinoid agonist binding by 5‐HT in the rat cerebellum
Devlin, M. G., & Christopoulos, A. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00797.x · Cited by 52
Mauler, F., Hinz, V. C., Augstein, K.-H., Faßbender, M., & Horváth, E. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03376-6 · Cited by 52
Kelley, B. G., & Thayer, S. A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.11.005 · Cited by 49
Goutopoulos, A., Fan, P., Khanolkar, A. D., Xie, X.-Q., Lin, S., & Makriyannis, A. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00088-8 · Cited by 49
Comparison of cannabinoid binding sites in guinea‐pig forebrain and small intestine
Ross, R. A., Brockie, H. C., Fernando, S. R., Saha, B., Razdan, R. K., & Pertwee, R. G. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702204 · Cited by 49
Self-citationInteraction of anandamide with the M1 and M4 muscarinic acetylcholine receptors
Christopoulos, A., & Wilson, K. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02825-6 · Cited by 48
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“Surprisingly, SR141716 and the CB2 antagonist SR144528 were also reported to have antiinflammatory effects (Smith et al., 2000, 2001), which may be attributed to their inverse agonist properties or to CB1/2 receptor-independent mechanisms (reviewed in Begg et al., 2005; Pertwee, 2005b,c).”
BackgroundPertwee, R. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 1,935
Self-citationPertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Di Marzo, V., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,605
Self-citationCannabinoid pharmacology: the first 66 years
Pertwee, R. G. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706406 · Cited by 782
Self-citationNeurobiological Interactions Between Stress and the Endocannabinoid System
Morena, M., Patel, S., Bains, J. S., & Hill, M. N. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.166 · Cited by 660
Metadata
- Authors
- Pertwee, R. G.
- Venue
- Handbook of Experimental Pharmacology
- Publisher
- Springer-Verlag
- Published
- 2005-12-23
- Issue
- 168
- Pages
- 1-51
- OpenAlex
- W2131899215
- Cited by
- 597
- References
- 218
- FWCI
- 52.09
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.